You are here

Dizal Pharmaceutical

FDA grants breakthrough status to Dizal’s sunvozertinib

Pharmaceutical Business Review

Mon, 04/8/24 - 11:54 am

Dizal Pharmaceutical

non-small cell lung cancer

ASH: With high tumor response, AstraZeneca spinout Dizal explores FDA path and US partner for PTCL drug

Fierce Biotech

Mon, 12/11/23 - 10:09 am

Dizal Pharmaceutical

peripheral T cell lymphoma

clinical trials

Dizal reports positive Phase I data for breast cancer therapy

Clinical Trials Arena

Tue, 09/6/22 - 10:37 am

Dizal Pharmaceutical

clinical trials

HER2-positive metastatic breast cancer

ASCO 2021 – the exon 20 army lines up behind Rybrevant

EP Vantage

Mon, 06/7/21 - 11:12 am

exon 20-insertion NSCLC

Dizal Pharmaceutical

Black Diamond Therapeutics

Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi

Endpoints

Fri, 08/21/20 - 12:45 pm

Lilly Asia Ventures

Dizal Pharmaceutical

AstraZeneca teams with China-owned fund to launch a new biopharma drug development company

Endpoints

Mon, 11/27/17 - 10:13 am

Dizal Pharmaceutical